Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04353531 · ClinicalTrials.gov registry record

Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures

A clinical trial, sponsored by Rush University Medical Center.

Completed
Registry status
15
Enrollment target

NCT04353531: Completed study, sponsored by Rush University Medical Center.

NCT04353531 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04353531 has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appears to be a trend to avoid those treatments. Instead, aggressive intubation might cause shortage of medical devices and add extra workload. Therefore, we aimed to do a clinical observational study to evaluate the aerosol generation in these procedures and explore the potential measures to reduce the aerosol generation or dispersion.

Primary Outcome

The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient's airway in the patient's room

Interventions

  • DEVICE High-flow nasal cannula
  • DEVICE Surgical mask
  • PROCEDURE bronchoscopy examination
  • PROCEDURE intubation
  • PROCEDURE tracheostomy

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-05-20
Est. Completion 2020-08-30
Rush University Medical Center

320 total trials

What the finished NCT04353531 record still lists

NCT04353531 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which High-flow nasal cannula is the first listed.

NCT04353531 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04353531 about?

NCT04353531 is a clinical study titled "Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures". Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appear...

What is the current status of trial NCT04353531?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-05-20. Estimated completion is 2020-08-30.

What interventions are being tested in trial NCT04353531?

The interventions under investigation include: High-flow nasal cannula (DEVICE), Surgical mask (DEVICE), bronchoscopy examination (PROCEDURE), intubation (PROCEDURE), tracheostomy (PROCEDURE).

Who is sponsoring clinical trial NCT04353531?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04353531, the US trial registry maintained by the National Library of Medicine. NCT04353531 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.